Cargando…

CRISPR/Cas9-mediated targeted chromosome elimination

BACKGROUND: The CRISPR/Cas9 system has become an efficient gene editing method for generating cells carrying precise gene mutations, including the rearrangement and deletion of chromosomal segments. However, whether an entire chromosome could be eliminated by this technology is still unknown. RESULT...

Descripción completa

Detalles Bibliográficos
Autores principales: Zuo, Erwei, Huo, Xiaona, Yao, Xuan, Hu, Xinde, Sun, Yidi, Yin, Jianhang, He, Bingbing, Wang, Xing, Shi, Linyu, Ping, Jie, Wei, Yu, Ying, Wenqin, Wei, Wei, Liu, Wenjia, Tang, Cheng, Li, Yixue, Hu, Jiazhi, Yang, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701507/
https://www.ncbi.nlm.nih.gov/pubmed/29178945
http://dx.doi.org/10.1186/s13059-017-1354-4
_version_ 1783281357459292160
author Zuo, Erwei
Huo, Xiaona
Yao, Xuan
Hu, Xinde
Sun, Yidi
Yin, Jianhang
He, Bingbing
Wang, Xing
Shi, Linyu
Ping, Jie
Wei, Yu
Ying, Wenqin
Wei, Wei
Liu, Wenjia
Tang, Cheng
Li, Yixue
Hu, Jiazhi
Yang, Hui
author_facet Zuo, Erwei
Huo, Xiaona
Yao, Xuan
Hu, Xinde
Sun, Yidi
Yin, Jianhang
He, Bingbing
Wang, Xing
Shi, Linyu
Ping, Jie
Wei, Yu
Ying, Wenqin
Wei, Wei
Liu, Wenjia
Tang, Cheng
Li, Yixue
Hu, Jiazhi
Yang, Hui
author_sort Zuo, Erwei
collection PubMed
description BACKGROUND: The CRISPR/Cas9 system has become an efficient gene editing method for generating cells carrying precise gene mutations, including the rearrangement and deletion of chromosomal segments. However, whether an entire chromosome could be eliminated by this technology is still unknown. RESULTS: Here we demonstrate the use of the CRISPR/Cas9 system to eliminate targeted chromosomes. Using either multiple cleavages induced by a single-guide RNA (sgRNA) that targets multiple chromosome-specific sites or a cocktail of multiple sgRNAs, each targeting one specific site, we found that a sex chromosome could be selectively eliminated in cultured cells, embryos, and tissues in vivo. Furthermore, this approach was able to produce a targeted autosome loss in aneuploid mouse embryonic stem cells with an extra human chromosome and human induced pluripotent stem cells with trisomy 21, as well as cancer cells. CONCLUSIONS: CRISPR/Cas9-mediated targeted chromosome elimination offers a new approach to develop animal models with chromosome deletions, and a potential therapeutic strategy for human aneuploidy diseases involving additional chromosomes. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13059-017-1354-4) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5701507
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-57015072017-12-04 CRISPR/Cas9-mediated targeted chromosome elimination Zuo, Erwei Huo, Xiaona Yao, Xuan Hu, Xinde Sun, Yidi Yin, Jianhang He, Bingbing Wang, Xing Shi, Linyu Ping, Jie Wei, Yu Ying, Wenqin Wei, Wei Liu, Wenjia Tang, Cheng Li, Yixue Hu, Jiazhi Yang, Hui Genome Biol Research BACKGROUND: The CRISPR/Cas9 system has become an efficient gene editing method for generating cells carrying precise gene mutations, including the rearrangement and deletion of chromosomal segments. However, whether an entire chromosome could be eliminated by this technology is still unknown. RESULTS: Here we demonstrate the use of the CRISPR/Cas9 system to eliminate targeted chromosomes. Using either multiple cleavages induced by a single-guide RNA (sgRNA) that targets multiple chromosome-specific sites or a cocktail of multiple sgRNAs, each targeting one specific site, we found that a sex chromosome could be selectively eliminated in cultured cells, embryos, and tissues in vivo. Furthermore, this approach was able to produce a targeted autosome loss in aneuploid mouse embryonic stem cells with an extra human chromosome and human induced pluripotent stem cells with trisomy 21, as well as cancer cells. CONCLUSIONS: CRISPR/Cas9-mediated targeted chromosome elimination offers a new approach to develop animal models with chromosome deletions, and a potential therapeutic strategy for human aneuploidy diseases involving additional chromosomes. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13059-017-1354-4) contains supplementary material, which is available to authorized users. BioMed Central 2017-11-24 /pmc/articles/PMC5701507/ /pubmed/29178945 http://dx.doi.org/10.1186/s13059-017-1354-4 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Zuo, Erwei
Huo, Xiaona
Yao, Xuan
Hu, Xinde
Sun, Yidi
Yin, Jianhang
He, Bingbing
Wang, Xing
Shi, Linyu
Ping, Jie
Wei, Yu
Ying, Wenqin
Wei, Wei
Liu, Wenjia
Tang, Cheng
Li, Yixue
Hu, Jiazhi
Yang, Hui
CRISPR/Cas9-mediated targeted chromosome elimination
title CRISPR/Cas9-mediated targeted chromosome elimination
title_full CRISPR/Cas9-mediated targeted chromosome elimination
title_fullStr CRISPR/Cas9-mediated targeted chromosome elimination
title_full_unstemmed CRISPR/Cas9-mediated targeted chromosome elimination
title_short CRISPR/Cas9-mediated targeted chromosome elimination
title_sort crispr/cas9-mediated targeted chromosome elimination
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701507/
https://www.ncbi.nlm.nih.gov/pubmed/29178945
http://dx.doi.org/10.1186/s13059-017-1354-4
work_keys_str_mv AT zuoerwei crisprcas9mediatedtargetedchromosomeelimination
AT huoxiaona crisprcas9mediatedtargetedchromosomeelimination
AT yaoxuan crisprcas9mediatedtargetedchromosomeelimination
AT huxinde crisprcas9mediatedtargetedchromosomeelimination
AT sunyidi crisprcas9mediatedtargetedchromosomeelimination
AT yinjianhang crisprcas9mediatedtargetedchromosomeelimination
AT hebingbing crisprcas9mediatedtargetedchromosomeelimination
AT wangxing crisprcas9mediatedtargetedchromosomeelimination
AT shilinyu crisprcas9mediatedtargetedchromosomeelimination
AT pingjie crisprcas9mediatedtargetedchromosomeelimination
AT weiyu crisprcas9mediatedtargetedchromosomeelimination
AT yingwenqin crisprcas9mediatedtargetedchromosomeelimination
AT weiwei crisprcas9mediatedtargetedchromosomeelimination
AT liuwenjia crisprcas9mediatedtargetedchromosomeelimination
AT tangcheng crisprcas9mediatedtargetedchromosomeelimination
AT liyixue crisprcas9mediatedtargetedchromosomeelimination
AT hujiazhi crisprcas9mediatedtargetedchromosomeelimination
AT yanghui crisprcas9mediatedtargetedchromosomeelimination